Clinical trial NCT05033639: Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis
Official title: Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis Among Preterm Infants In A Tertiary Level Hospital In The Philippines: A Randomized Control Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE1
PHASE2
Conditions: Necrotizing Enterocolitis
Lead sponsor: Ilocos Training and Regional Medical Center
Sponsor class: OTHER_GOV
Collaborators: name: Vayu Global Foundation
First posted: 2021-09-05
Enrollment: 100
Sex: ALL
Minimum age (years): 28
Maximum age (years): 36
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: This is a double-blind Randomized Control trial where melatonin would be the interventions given to preterm infants admitted at the Neonatal Intensive Care Unit of Ilocos Training and Regional Medical Center.
Primary purpose: PREVENTION

Brief summary: Prematurity is still one of the primary causes of death in children under 5. 1-2. According to the WHO, 60% of all preterm births occur in Asia, with the Philippines accounting for around 348,900 every year. 3. Necrotizing enterocolitis is one of the fatal complications (NEC) 3, 4. Preterm newborns weighing 1500 grams or less are considered high risk. 5-6.

Melatonin is one chemical that may help prevent NEC. Melatonin is an endogenous indolamine derived from serotonin. It is a ubiquitous molecule that is crucial to the body's physiologic function. Melatonin, also known as N-acetyl-5-methoxytryptamine, is an immunomodulator, antioxidant, anti-inflammatory, and free radical scavenger7-10.

It is a naturally occurring chemical that is simply replenished. With this in mind, the researcher wants to see if providing high dose melatonin to premature babies can prevent NEC.

Detailed description: Prematurity remains as one of the leading causes of mortality among children less than 5 years old1-2. The World Health Organization that 60 percent of all preterm births around the world occurs in Asian countries and roughly 348,900 births occur each year in the Philippines3. One complication that contribute to the high mortality is necrotizing enterocolitis (NEC)1, 3-4. High risk population include preterm infants weighing 1500 grams and lower with inverse correlation to the patient's weight5-6.

One compound that could be used to prevent NEC is melatonin. Melatonin is an endogenously produced indolamine principally synthesized in the pineal gland from serotonin. It is described as a ubiquitous molecule which plays a vital role in the physiologic function of the body. Melatonin, also known as N-acetyl-5-methoxytryptamine which has a a) immunomodulator; b) free radical scavenger; c) prevention of oxidative stress and d) anti-inflammatory7-10.

It is a naturally occurring substance and it would just be supplemented to increase its levels. With all this in mind, the researcher would like to determine if giving high dose melatonin among preterm neonates could prevent NEC among high risk population.

Eligibility criteria: Inclusion Criteria:

* 1. Newborn with a pediatric age of less than 37 weeks categorized very preterm (28 to 32 weeks) and late preterm (32 to 36weeks) by the World Health Organization weighing not more than 1500.

  2. Preterm infants admitted at the Neonatal Intensive care unit of Ilocos Training Regional and Medical Center not more than 24 hours of age.

  3. Preterm infants with orogastric tube in place. 4. Preterm infants with no other condition other than prematurity and respiratory distress syndrome.

  5. Preterm infant with an Apgar score of more than 6 in the first minute of life.

Exclusion Criteria:

1. Preterm infants more than 1 day of life.
2. Preterm infants diagnosed with NEC
3. Preterm infants who is born to a mother of who considered as a minor (\<18 years old) and is not married to the father of the unborn child.
4. Preterm infants that could not be fed through oral gastric tube due to a secondary problem.
5. Preterm infants with other comorbidities such as asphyxia, congenital anomalies, and other inherited disorders.
6. Meconium Stained Preterm infants

   -

Primary outcomes:
measure: Number Of Preterm Infants Who Developed Necrotizing Enterocolits After Melatonin 6mg Tablet Prophylaxis
timeFrame: 5 MONTHS
Secondary outcomes:
measure: Incidence of Prematurity at Training and Regional Medical Center
timeFrame: 5 MONTHS
measure: Number of Patients Who Developed Abnormal Gas Pattern with Dilated Bowel Loops after Melatonin 6mg Tablet Prophylaxis
timeFrame: 5 MONTHS
measure: Number of Patients Who Developed Pneumatosis intestinalis after Melatonin 6mg Tablet Prophylaxis
timeFrame: 5 Months
measure: Number of Patients Who Developed Sentinel Loops after Melatonin 6mg Tablet Prophylaxis
timeFrame: 5 Months
measure: Number of Patients Who Developed Portal Venous Gas after Melatonin 6mg Tablet Prophylaxis
timeFrame: 5 Months
measure: Number Of Hospital Days Among Preterm Infants Admitted at Ilocos Training and Regional Medical Center
timeFrame: 5 Months
measure: Number Of Days Before Oral FeedingAmong Preterm Infants Admitted at Ilocos Training and Regional Medical Center
timeFrame: 5 motnhs
Other outcomes:
Locations:
city: San Fernando
country: Philippines
facility: Ilocos Training and Regional Medical Center
state: LA Union
Study officials:
affiliation: Ilocos Training and Regional Medical Center
name: Daisy Evangeline C Garcia, MD
role: STUDY_DIRECTOR
affiliation: ITRMC
name: Navid P Roodaki, MD
role: PRINCIPAL_INVESTIGATOR
References: